Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tan Chuan Dripping Pills is a traditional Chinese medicine (TCM) formulation developed by Hainan Haochuang Pharmaceutical for the treatment of chronic bronchitis. The product is a dripping pill formulation containing active alkaloids, primarily matrine and oxymatrine, which are typically extracted from *Sophora* species such as *Sophora flavescens*. These alkaloids possess anti-inflammatory, antitussive, and expectorant properties, making them effective in reducing phlegm and relieving cough and asthma-like symptoms. In clinical trials, the dripping pill formulation has been evaluated for bioequivalence against traditional Tan Chuan tablets, with pharmacokinetic assessments focusing on the absorption and disposition of matrine and oxymatrine. The drug is often administered in conjunction with Huangbo fruit oil (Vitex oil) soft capsules to enhance its therapeutic effect on the respiratory system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tan Chuan Dripping Pills.